Received August 11, 2025
Accepted September 04, 2025

Assisted Reproductive Technologies (ART) demand rigorous quality standards to ensure clinical safety, efficacy, and ethical responsibility. This review outlines key elements of Quality Management Systems (QMS) in ART laboratories, addressing technical, infrastructural, regulatory, and human dimensions essential to successful outcomes. Core components include standardized protocols, validation and maintenance of equipment, environmental monitoring, biosafety procedures, and robust traceability. Laboratory infrastructure must meet ISO cleanroom standards to support the microenvironment necessary for gamete and embryo viability. Biosafety in ART requires BSL-2 compliance, risk zoning, personal protective equipment, proper waste disposal, and comprehensive training, including ergonomic and psychological safety measures. Personnel qualification is essential, requiring academic credentials, continuing education, and structured competency assessments. Equipment such as incubators and cryogenic tanks must undergo regular validation, given their direct impact on embryo development. Performance indicators (KPIs), including fertilization, blastocyst formation, and cryosurvival rates, serve as benchmarks for quality improvement. Documentation and traceability systems must track all clinical and laboratory stages, supported by electronic platforms and witnessing systems. Regulatory adherence and accreditation by agencies reinforce institutional reliability and transparency. Ethical compliance remains foundational, including informed consent, embryo disposition policies, and data confidentiality. While the implementation of a comprehensive QMS involves significant investment, it yields measurable benefits: improved clinical outcomes, error reduction, enhanced patient satisfaction, and long-term sustainability. Quality management in ART is thus not only a regulatory mandate but a strategic imperative that aligns technological precision with ethical and clinical excellence.